ARB-204

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameARB-204

Drug Alias NameARB-204

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionCadherin-17 modulatorsProgrammed cell death protein 1 modulators

TargetsCadherin-17Programmed cell death protein 1

Therapy Area/IndicationsGastrointestinal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesArbele Corp

China Registration ClassN/A

Develop Information

Active CompaniesArbele Corp

Inactive CompaniesN/A

Active IndicationsGastrointestinal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A